Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea
Status:
Withdrawn
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The study will compare durations of diarrhea among subjects who report to clinic for
treatment and who receive either:
1. standard rifaximin therapy at a dose of 200 mg three times a day for 3 days, OR
2. a single 600 mg dose of rifaximin daily for 3 days.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston